Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Samid

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|August 20, 1992
Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrateG J Dover, S Brusilow, D Samid
The Journal of Urology|May 1, 1996
Phenylacetate is an inhibitor of prostatic growth and development in organ cultureJ H Lipschutz, D Samid, G R Cunha
Bioprocess Technology|January 1, 1991
Advances toward somatic cell gene therapyD Samid, W F Anderson, R C Moen
Biochemical and Biophysical Research Communications|February 29, 1984
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogeneD Samid, E H Chang, R M Friedman
Molecular and Cellular Biology|June 1, 1987
Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidineD Samid, D M Flessate, R M Friedman
Biochemical and Biophysical Research Communications|January 16, 1985
Development of transformed phenotype induced by a human ras oncogene is inhibited by interferonD Samid, E H Chang, R M Friedman
International Journal of Cancer|July 31, 2001
Inhibition of estrogen-dependent breast cell responses with phenylacetateS Sawatsri, D Samid, S Malkapuram, et al.
Journal of Neurochemistry|February 1, 1996
Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cellsP Prasanna, A Thibault, L Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cellsS D Gore, D Samid, L J Weng
International Journal of Radiation Biology|August 1, 1997
Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrateA C Miller, T Whittaker, A Thibault, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|August 20, 1992
Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrateG J Dover, S Brusilow, D Samid
The Journal of Urology|May 1, 1996
Phenylacetate is an inhibitor of prostatic growth and development in organ cultureJ H Lipschutz, D Samid, G R Cunha
Bioprocess Technology|January 1, 1991
Advances toward somatic cell gene therapyD Samid, W F Anderson, R C Moen
Biochemical and Biophysical Research Communications|February 29, 1984
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogeneD Samid, E H Chang, R M Friedman
Molecular and Cellular Biology|June 1, 1987
Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidineD Samid, D M Flessate, R M Friedman
Biochemical and Biophysical Research Communications|January 16, 1985
Development of transformed phenotype induced by a human ras oncogene is inhibited by interferonD Samid, E H Chang, R M Friedman
International Journal of Cancer|July 31, 2001
Inhibition of estrogen-dependent breast cell responses with phenylacetateS Sawatsri, D Samid, S Malkapuram, et al.
Journal of Neurochemistry|February 1, 1996
Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cellsP Prasanna, A Thibault, L Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cellsS D Gore, D Samid, L J Weng
International Journal of Radiation Biology|August 1, 1997
Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrateA C Miller, T Whittaker, A Thibault, et al.
Pageof 7